Prophylaxis with OKT3 at half dose.: A prospective study.

被引：0
|
作者：
Nunez, MLS [1 ]
Gómez, E [1 ]
Tricas, L [1 ]
Aguado, S [1 ]
de Oña, M [1 ]
Portal, C [1 ]
Baltar, J [1 ]
Navascues, R [1 ]
Laures, A [1 ]
Grande, JA [1 ]
机构：
[1] Hosp Cent Asturias, Nephrol & Immunol Serv, Oviedo, Spain
来源：
KIDNEY INTERNATIONAL | 1999年 / 55卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [31] OKT3 prophylaxis in kidney transplant recipients: Drug monitoring by flow cytometry
    Cinti, P
    Cocciolo, P
    Evangelista, B
    Orlandini, AM
    Bruzzone, P
    Molajoni, ER
    Cortesini, R
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3214 - 3216
  • [32] PROSPECTIVE RANDOMIZED TRIAL OF OKT3 VERSUS HORSE ANTITHYMOCYTE GLOBULIN BASED IMMUNOSUPPRESSIVE PROPHYLAXIS IN HEART-TRANSPLANTATION
    COSTANZONORDIN, MR
    OSULLIVAN, EJ
    JOHNSON, MR
    WINTERS, GL
    PIFARRE, R
    RADVANY, R
    ZUCKER, MJ
    SCANLON, PJ
    ROBINSON, JA
    JOURNAL OF HEART TRANSPLANTATION, 1990, 9 (03): : 306 - 315
  • [33] A PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOPHOSPHAMIDE AND AZATHIOPRINE FOR EARLY REJECTION PROPHYLAXIS AFTER CARDIAC TRANSPLANTATION - DECREASED SENSITIZATION TO OKT3
    TAYLOR, DO
    BRISTOW, MR
    OCONNELL, JB
    ENSLEY, RD
    OLSEN, SL
    HAMMOND, EH
    WAGONER, LE
    RENLUND, DG
    TRANSPLANTATION, 1994, 58 (06) : 645 - 649
  • [34] A randomized prospective trial of OKT3 induction in the current immunosuppression era
    Henry, ML
    Pelletier, RP
    Elkhammas, EA
    Bumgardner, GL
    Davies, EA
    Ferguson, RM
    CLINICAL TRANSPLANTATION, 2001, 15 (06) : 410 - 414
  • [35] HIGH-DOSE GLUCOCORTICOSTEROIDS INCREASE THE PROCOAGULANT EFFECTS OF OKT3
    ABRAMOWICZ, D
    PRADIER, O
    DEPAUW, L
    KINNAERT, P
    MAT, O
    SURQUIN, M
    DOUTRELEPONT, JM
    VANHERWEGHEM, JL
    CAPEL, P
    VEREERSTRAETEN, P
    GOLDMAN, M
    KIDNEY INTERNATIONAL, 1994, 46 (06) : 1596 - 1602
  • [36] STANDARD VERSUS LOW-DOSE OKT3 INDUCTION THERAPY OF CADAVERIC RENAL-TRANSPLANTS - COMPARISON OF OUTCOME DATA VERSUS OKT3 DOSE AND SERUM LEVELS
    ALLOWAY, RR
    KOTB, M
    GABER, LW
    VERA, SR
    BOSKEY, F
    GABER, AO
    CLINICAL TRANSPLANTATION, 1992, 6 (06) : 468 - 472
  • [37] LOW-DOSE OKT3 FOR CADAVERIC RENAL-TRANSPLANTATION
    SCHWEIZER, RT
    ROPER, L
    HULL, D
    BARTUS, SA
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 2592 - 2593
  • [38] RESULTS OF A PROSPECTIVE, RANDOMIZED DOUBLE-BLIND-STUDY COMPARING STANDARD VS LOW-DOSE OKT3 INDUCTION THERAPY
    ALLOWAY, R
    KOTB, M
    HATHAWAY, DK
    GABER, LW
    VERA, SR
    GABER, AO
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 550 - 552
  • [39] A PROSPECTIVE COMPARISON OF MURINE MONOCLONAL CD-3 (OKT3) ANTIBODY-BASED AND EQUINE ANTITHYMOCYTE GLOBULIN-BASED REJECTION PROPHYLAXIS IN CARDIAC TRANSPLANTATION - DECREASED REJECTION AND LESS CORTICOSTEROID USE WITH OKT3
    RENLUND, DG
    OCONNELL, JB
    GILBERT, EM
    HAMMOND, ME
    BURTON, NA
    JONES, KW
    KARWANDE, SV
    DOTY, DB
    MENLOVE, RL
    HERRICK, CM
    LEE, HR
    GAY, WA
    BRISTOW, MR
    TRANSPLANTATION, 1989, 47 (04) : 599 - 605
  • [40] Pharmacoeconomic advantages of CD3 guided dose titration of orthoclone (OKT3)
    Wiland, A
    Fink, J
    Kurth, S
    Weir, M
    Bartlett, S
    TRANSPLANTATION, 1999, 67 (07) : S186 - S186
12345